Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- None.
- None.
A live webcast of the presentation will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. After the webcast, a replay will be archived on the website for at least 30 days.
About Xencor
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240103100031/en/
Charles Liles
cliles@xencor.com
626-737-8118
Source: Xencor, Inc.
FAQ
When is the 42nd Annual J.P. Morgan Healthcare Conference?
What is the ticker symbol for Xencor, Inc.?
What does Xencor, Inc. specialize in?
Where can I watch the presentation by Bassil Dahiyat, Ph.D.?
How long will the presentation replay be archived?
